Low birth weight and elevated head-to-abdominal circumference ratio are associated with elevated fetal glycated serum protein concentrations

Journal of Hypertension

Volumn 29, Issue 9, 2011, Pages 1712-1718

  Li, Jian ^a   Wang, Zi Neng ^a   Schlemm, Ludwig ^c,d   Pfab, Thiemo ^a,d   Xiao, Xiao Min ^a   Chen, You Peng ^b   Hocher, Berthold ^a,c,d  

^a Department of Obstetrics and Gynecology ^*  (Germany)

^b JINAN UNIVERSITY   (China)

^c UNIVERSITY OF POTSDAM   (Germany)

^d Institute of Pharmacology   (Germany)

Author keywords

disproportional intrauterine growth retardation; insulin resistance; low birth weight; ultrasound

Indexed keywords

FETOPROTEIN; GLUCOSE; GLYCATED SERUM PROTEIN; GLYCOSYLATED PROTEIN; UNCLASSIFIED DRUG;

ABDOMEN; ADULT; ARTICLE; BIPARIETAL DISTANCE; BODY MASS; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FEMUR; FETUS BLOOD; FETUS ECHOGRAPHY; GESTATIONAL AGE; GLYCEMIC CONTROL; HEAD CIRCUMFERENCE; HEAD TO ABDOMINAL CIRCUMFERENCE RATIO; HUMAN; INSULIN RESISTANCE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL BLOOD; MATERNAL HYPERTENSION; NEWBORN; ORAL GLUCOSE TOLERANCE TEST; PECTORAL DIAMETER; PREMATURE LABOR; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; SEX DIFFERENCE; THORAX; UMBILICAL CORD BLOOD;

EID: 80051930627     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328349a2e6     Document Type: Article

References (31)

1. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991; 303:1019-1022.
2. Leon DA, Koupil I, Mann V, Tuvemo T, Lindmark G, Mohsen R, et al. Fetal, developmental, and parental influences on childhood systolic blood pressure in 600 sib pairs: the Uppsala Family study. Circulation 2005; 112:3478-3485. (Pubitemid 43739564)
3. Clausen JO, Borch-Johnsen K, Pedersen O. Relation between birth weight and the insulin sensitivity index in a population sample of 331 young, healthy Caucasians. Am J Epidemiol 1997; 146:23-31. (Pubitemid 27291363)
4. Phipps K, Barker DJ, Hales CN, Fall CH, Osmond C, Clark PM. Fetal growth and impaired glucose tolerance in men and women. Diabetologia 1993; 36:225-228. (Pubitemid 23067083)
5. Rich-Edwards JW, Colditz GA, Stampfer MJ, Willett WC, Gillman MW, Hennekens CH, et al. Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern 1999; 130 (4 Pt 1):278-284. (Pubitemid 29091855)
6. Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA. Relation of size at birth to noninsulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 1996; 312:406-410. (Pubitemid 26055355)
7. Mi J, Law C, Zhang KL, Osmond C, Stein C, Barker D. Effects of infant birthweight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China. Ann Intern Med 2000; 132:253-260. (Pubitemid 30106255)
8. Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 1999; 353:1789-1792. (Pubitemid 29240389)
9. Barker DJ, Bagby SP. Developmental antecedents of cardiovascular disease: a historical perspective. J Am Soc Nephrol 2005; 16:2537-2544.
10. Reusch JE. Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome. Am J Cardiol 2002; 90:19G-26G. (Pubitemid 35266677)
11. Goldman SL, Hirata T. Attenuated response to insulin in very low birthweight infants. Pediatr Res 1980; 14:50-53. (Pubitemid 10209378)
12. Pollak A, Cowett RM, Schwartz R, Oh W. Glucose disposal in low-birthweight infants during steady-state hyperglycemia: effects of exogenous insulin administration. Pediatrics 1978; 61:546-549. (Pubitemid 8299737)
13. Wang X, Cui Y, Tong X, Ye H, Li S. Glucose and lipid metabolism in smallfor-gestational-age infants at 72 h of age. J Clin Endocrinol Metab 2007; 92:681-684.
14. Pfab T, Slowinski T, Godes M, Halle H, Priem F, Hocher B. Low birth weight, a risk factor for cardiovascular diseases in later life, is already associated with elevated fetal glycosylated hemoglobin at birth. Circulation 2006; 114:1687-1692. (Pubitemid 44607116)
15. Li H. The application of ultrasound in fetal monitoring. Chin J Pract Gynecol Obstet 2010; 26:89-92.
16. Xie Y, Zhang J, Li S. Effect of pregnancy body mass index on pregnant outcomes in women with abnormal glucose challenge test and normal oral glucose tolerance test. Prog Obstet Gynecol 2007; 16:440-442.
17. Tang C, Fan J. The investigation of tobacco exposure during pregnancy. Chin J Birth Health Hered 2010; 18:4-6.
18. Armbruster DA. Fructosamine: structure, analysis, and clinical usefulness. Clin Chem 1987; 33:2153-2163.
19. Benjamin RJ, Sacks DB. Glycated protein update: implications of recent studies, including the diabetes control and complications trial. Clin Chem 1994; 40:683-687. (Pubitemid 24142839)
20. Milner RD, Hales CN. Effect of intravenous glucose on concentration of insulin in maternal and umbilical-cord plasma. BMJ 1965; 1:284-286.
21. Godfrey KM, Hales CN, Osmond C, Barker DJ, Taylor KP. Relation of cord plasma concentrations of proinsulin, 32-33 split proinsulin, insulin and Cpeptide to placental weight and the baby's size and proportions at birth. Early Hum Dev 1996; 46:129-140. (Pubitemid 26341123)
22. Xu X, Ceng H, Yu J. The significance of glycosylated serum protein measurement for monitoring diabetes mellitus. Lab Med 2006; 21:139.
23. O'Brien JE, Brookes M. Determination of reference values for a novel ketoamine-specific fructosamine assay for assessment of diabetic glycemic control. Diabetes Technol Ther 1999; 1:447-455.
24. Hogberg U, Lekas Berg M. Prolonged labour attributed to large fetus. Gynecol Obstet Invest 2000; 49:160-164. (Pubitemid 30195646)
25. al-Ghazali W, Chita SK, Chapman MG, Allan LD. Evidence of redistribution of cardiac output in asymmetrical growth retardation. Br J Obstet Gynaecol 1989; 96:697-704. (Pubitemid 19172190)
26. Baschat AA. Fetal responses to placental insufficiency: an update. BJOG 2004; 111:1031-1041. (Pubitemid 39319260)
27. Sadiq HF, Das UG, Tracy TF, Devaskar SU. Intra-uterine growth restriction differentially regulates perinatal brain and skeletal muscle glucose transporters. Brain Res 1999; 823:96-103. (Pubitemid 29225498)
28. Dos Santos Rizzi MC, Araujo Junior E, Nardozza LM, Diniz AL, Rolo LC, Moron AF. Nomogram of fetal liver volume by three-dimensional ultrasonography at 27 to 38 weeks of pregnancy using a new multiplanar technique. Am J Perinatol 2010; 27:641-648.
29. Vintzileos AM, Neckles S, Campbell WA, Andreoli JW Jr, Kaplan BM, Nochimson DJ. Fetal liver ultrasound measurements during normal pregnancy. Obstet Gynecol 1985; 66:477-480. (Pubitemid 16236429)
30. Bueno MP, Barini R, Goncalves FL, Verissimo RP, Sbragia L. Experimental rat model for fetal growth restriction: effects on liver glycogen and intestinal and renal morphometry. Rev Bras Gynecol Obstet 2010; 32:163-168.
31. Barker DJ, Martyn CN, Osmond C, Hales CN, Fall CH. Growth in utero and serum cholesterol concentrations in adult life. BMJ 1993; 307:1524-1527.